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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Cisplatin induces 
fratricide among 
tubular cells
A useful agent in the treatment of cancer, 
cisplatin is limited by its renal toxicity, 
which causes apoptosis of renal tubular 
cells. The mechanism appears to be due to 
the presence of Fas, a receptor for Fas lig-
and (FasL), on the epithelial cells. As well 
as infiltrating immune cells, these cells 
express the ligand and mediate apoptosis. 
As they report in this issue, Linkermann et 
al. studied whether the presence of the lig-
and on the tubular epithelial cells is critical 
for renal injury. They found that whereas 
all wild-type mice died after a certain dose 
of cisplatin, those lacking all immune 
cells were protected somewhat, with only 
about half dying. Treatment of these defi-
cient mice with a FasL-blocking antibody 
improved survival completely, suggesting 
tubular epithelial cells as another source 
of FasL. It was then demonstrated that 
cultured tubular epithelial cells treated 
with cisplatin were able to kill untreated 
epithelial cells, showing that a tubular epi-
thelial cell is capable of killing its neighbor 
without the involvement of immune cells. 
See page 169.
Ultrafiltration during 
dialysis and mortality
Patients on hemodialysis have a higher 
incidence of cardiovascular morbidity 
and mortality. The cause of this higher 
prevalence is probably complex, including 
the traditional risk factors of higher inci-
dences of hypertension and diabetes and 
also a higher incidence of vascular calcifi-
cation and more accelerated atherosclero-
sis. However, three-times-weekly dialysis 
must impose some hemodynamic stress, 
especially, as is often the case, when fluid is 
removed. As they report in this issue, Flythe 
et al. analyzed the data from the Hemo-
dialysis Study of almost 2000 patients and 
divided them into three categories based 
on how much fluid was removed in each 
session and on whether the patients had 
congestive heart failure. When the rate of 
removal of fluid was small (10–13 ml/h/
kg), there did not seem to be any associa-
tion with mortality, unless the patients had 
congestive failure. Mortality appeared to 
increase as the volume of ultrafiltered fluid 
increased above 10 ml/h/kg, regardless of 
the presence or absence of heart failure. 
Of course, these associations do not imply 
causality, which is difficult to demonstrate 
in association studies. See page 250.
Distance makes the 
kidney weaker
Follow-up of patients with chronic kidney 
disease (CKD) is necessary to prevent, or at 
least slow down, progression to end-stage 
renal disease, arguably offering the most 
helpful impact on patient well-being of any 
available intervention. However, follow-up 
can appear to a skeptical or cynical eye to 
be yet another way for specialists to make 
more money. Rucker et al. devised a nice 
strategy to test whether seeing a nephrolo-
gist actually is good for the patient with 
CKD, using a database for Alberta, Canada, 
where more than 30,000 outpatients were 
enrolled whose estimated glomerular fil-
tration rates were lower than normal. They 
then analyzed the more than 6000 patients 
who lived farther than 50 km from the 
nearest nephrologist and followed them for 
more than two years. Compared with those 
living within the 50-km radius, those living 
far did not visit a nephrologist as often, nor 
did they have either their hemoglobin A1c 
or their urinary albumin excretion meas-
ured. Most importantly, they were also 
less likely to have angiotensin-converting 
enzyme inhibitors or angiotensin receptor 
blockers prescribed. Of the more than 7000 
deaths in the combined cohort, patients liv-
ing farther were more likely to die and less 
likely to be hospitalized. See page 210.
